Annual General Meeting

GSK plc (GSK) holds an Annual General Meeting (AGM) in London each year during May. All the directors able to attend are available formally during the meeting for questions.



Voting on all resolutions put to the Annual General Meeting is done by way of a poll rather than by a show of hands.

2023 AGM Overview

Our AGM will be held at 2.30pm on Wednesday 3 May 2023 at the Sofitel London Heathrow, Terminal 5, London Heathrow Airport, TW8 2GD. The AGM will also be broadcast live for shareholders who wish to join electronically.

The Notice of Annual General Meeting 2023 (2023 AGM Notice) gives details on the resolutions to be put to the AGM, together with explanatory notes.

We are providing shareholders with two methods of joining the AGM – either electronically or in person. You are encouraged to participate in the meeting electronically as this will provide you with the full AGM experience without the need to travel.

Full details on how to participate in this year’s AGM, ask questions and vote before and during the meeting can be found on pages 36 to 40 of the 2023 AGM Notice and in our AGM Guide. They are also summarised below.

Any shareholders with questions on how to access the AGM should contact our registrar, Equiniti, who will be pleased to talk through the joining options. Their contact details can be found on page 43 of the 2023 AGM Notice and here.

Electronic meeting

If you wish to join the meeting electronically, the Lumi AGM website will enable you to:

  • watch and listen to the meeting;
  • ask questions of the Board orally or in writing; and
  • submit your vote,

through the same platform.

Shareholders will need their SRN and PIN to join the meeting which can be found on their Proxy Form, Form of Direction or voting email from Equiniti.

The AGM will be broadcast in video format with presentation slides. If you participate via the Lumi AGM website you will be able to watch and listen to the proceedings of the meeting and see the text of the resolutions to be put to the meeting. Presentation slides will be used during the meeting and will more forward automatically as the meeting progresses.

Physical meeting

If you wish to attend the meeting in person, please bring your Proxy Form or Form of Direction with you and try to arrive by 1.30pm to allow for registration and security clearance.

Shareholders are encouraged to monitor this page in advance of the AGM to ensure they are informed of any changes or restrictions on physical attendance.


In advance of the AGM

Shareholders are encouraged to vote on the AGM resolutions. This can be done in advance of the meeting by completing a Proxy Form or submitting proxy instructions electronically. Proxy instructions must be received by Equiniti by 2.30pm (UK time) on Friday 28 April 2023.

Participants in the GSK Corporate Sponsored Nominee Service can exercise their voting rights through Equiniti by completing a Form of Direction or submitting voting instructions electronically. Instructions must be received by Equiniti by 5.00pm (UK time) on Wednesday 26 April 2023.

Any holder of GSK shares through a nominee service should contact their nominee service provider regarding the process for appointing a proxy to vote on their behalf. The deadline for this will be before Friday 28 April 2023. Such holders are therefore advised to contact their nominee service provider well in advance of this date. 

Further details on the appointment of proxies can be found on pages 19 to 22 of the 2023 AGM Notice.

During the meeting

Shareholders can vote at the AGM electronically by participating in the meeting through the Lumi AGM website. Further details can be found on pages 36 to 40 of the 2023 AGM Notice and in the AGM Guide.​​

Shareholders attending the meeting in person can vote by completing the poll card which you will receive on registration at the AGM.


Shareholders may submit typed questions in advance of the AGM via the Lumi AGM website from 5.00pm (UK time) on Monday 27 March 2023 until 5.00pm (UK time) on Monday 1 May 2023.  These questions will not be answered ahead of the AGM but will be collated to be answered during the Q&A session at the AGM. Please note that advance questions submitted via the Lumi AGM website should only relate to the business of the meeting. Any questions concerning meeting logistics or your own shareholding should be directed to Equiniti whose contact details can be found on page 43 of the 2023 AGM Notice and here.

Shareholders joining the meeting electronically will be able to submit questions during the meeting via the Lumi AGM website, either by clicking into the messaging tab and typing and submitting a question, or indicating you wish to ask a question orally via the embedded webinar. Details on how to participate in the meeting via these means are provided on pages 36 to 40 of the 2023 AGM Notice and in the AGM Guide.

If you wish to ask a question via video, you can do so by joining the meeting from a separate Zoom call. If you wish to do this, you must pre-register by sending an email to by 5.00pm (UK time) on Thursday 27 April 2023. You will then be emailed a link to the Zoom meeting with detailed joining instructions.

The Chair will invite shareholders to ask questions at the physical meeting using designated question points.

Questions will alternate between those from shareholders at the physical meeting and those asked via the Lumi AGM website and Zoom.

Total Voting Rights

In accordance with section 311A of the Companies Act 2006, GSK confirms that as at 24 March 2023, its issued share capital (excluding Treasury shares) consisted of 4,094,943,723 ordinary shares of 31 ¼ pence each, carrying one vote each. Therefore, the total voting rights that members were entitled to exercise at the AGM in respect of these shares is 4,094,943,723.

Previous AGMs

Information about our previous Annual General Meetings is available from the AGM archive tab above.


The following AGM documents are available to download:

Information on requisitioning a resolution for the AGM

AGM archive

Back to top